PubMed COVID-19 Clinical Care
3091 - 3100 of 5244 results found
Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: A case study using spike protein of SARS-CoV-2
Description
In the recent past several vaccines were developed to combat the COVID-19 disease. Unfortunately, the protective efficacy of the current vaccines has been reduced due to the high mutation rate in SARS-CoV-2. Here, we successfully implemented a
Cardiac arrhythmia and immune response in COVID-19 patients
Description
The coronavirus disease 2019 (COVID-19) pandemic has presented substantial challenges for providing health care due to the numerous complications on the respiratory and cardiovascular systems of people. Cardiac arrhythmia is one of the cardiac
Cotranslational formation of disulfides guides folding of the SARS CoV-2 receptor binding domain
Description
Many secreted proteins, including viral proteins, contain multiple disulfide bonds. How disulfide formation is coupled to protein folding in the cell remains poorly understood at the molecular level. Here, we combine experiment and simulation to
Context-aggregator: An approach of loss- and class imbalance-aware aggregation in federated learning
Description
Federated Learning (FL) is an emerging distributed learning paradigm which offers data privacy to contributing nodes in the collaborating environment. By exploiting the Individual datasets of different hospitals in FL setting could be used to develop
Cellular immunity reflects the persistent symptoms among COVID-19 recovered patients in Japan
Description
Coronavirus disease (COVID-19) often causes persistent symptoms long after infection, referred to as "long COVID" or post-acute COVID-19 syndrome (PACS). This phenomenon has been studied primarily concerning B-cell immunity, while the involvement of
Cladribine Tablets Mode of Action, Learning from the Pandemic: A Narrative Review
Description
Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system, characterized by chronic, inflammatory, demyelinating, and neurodegenerative processes. MS management relies on disease-modifying drugs that suppress/modulate the
